Setup, so nobody has to ask: TSH · magnesium · tirzepatide.
I want to know what the trade-off actually is rather than which option is fashionable.
I would rather have a defensible reason than a marginal improvement.
Which axes does this decision turn on?
The short version: a small, well-chosen panel with a baseline beats a large one without.
Delta checks — comparing against your own previous value — are far more sensitive than comparing against a population interval, which is the argument for keeping a series rather than a snapshot.
Timing matters per analyte: cortisol and testosterone are diurnal, triglycerides are postprandial, and creatinine responds to hydration and to recent training. Fixing the conditions removes most of the noise.
Reference intervals are conventionally the central ninety-five per cent of a reference population, which is the direct cause of the one-in-twenty out-of-range rate on a healthy panel.
Keep the full report, not the number. You will need the units and the interval later.
edited 15 Apr 2026 by Dr_Colm_Fitzhenry — clarified the distinction between purity and content
Analytical standards and reagents with traceable certificates. Every quantitative result you read inherits the accuracy of the standard behind it.
Shop standardsStandardise the conditions — same time of day, same fasting state, same laboratory — or you are measuring the conditions rather than yourself.
A sensible core for this population is a full blood count, renal function with electrolytes, liver enzymes with bilirubin, a fasting lipid panel with apolipoprotein B, HbA1c and thyroid-stimulating hormone.
Same laboratory, same method, same time of day, same fasting state. Between-laboratory differences on several common analytes are larger than the changes people are trying to detect.
Same laboratory, same time, same fasting state, or the comparison is not a comparison.
Before reacting to any single value, check whether it is outside the interval by an amount larger than the assay's own variation.
A twenty-analyte panel run on a healthy person will produce, on average, one out-of-range result purely from how reference intervals are constructed. That is arithmetic rather than pathology.
Keep the reports rather than the numbers. Units, reference intervals and methods all vary, and a bare number two years later is not comparable to anything.
Biological variation data are published per analyte and are the basis for the reference change value — the difference between two results that is larger than noise.
Decide the action for each result before you order the test.
The relevant statistical point is that a ninety-five per cent reference interval means one analyte in twenty will read out of range in a healthy person by construction.
Repeat before you react. A single abnormal value has a substantial probability of being within the combined biological and analytical variation of a normal one.
External quality assurance schemes document between-laboratory differences on common analytes that routinely exceed the size of clinically interesting changes.
The caveat is that a panel is not a diagnosis and interpreting one is a clinician's job, particularly when several values move together.
One out-of-range value on a twenty-analyte panel is expected. Two on a repeat is a finding.
This is answerable, and the answer is mostly about which tests rather than how many.
Haemolysis in the sample raises potassium and several enzymes spuriously. If a result is bizarre, ask whether the sample was flagged before building a theory on it.
Research-use compounds are not approved for human use, and no panel makes that safer.
Baseline first, then a repeat under identical conditions. Everything else is secondary.
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.